REQUEST A DEMO
Total
USD $0.00
Search more companies

Bio Dyne Co.,Ltd. (South Korea)

Main Activities: Surgical and Medical Instrument Manufacturing
Full name: Bio Dyne Co.,Ltd. Profile Updated: March 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

The company is a Korea-based company mainly engaged in the production and sales of liquid based cytology (LBC) diagnostic reagent kits. The Company was established on October 8, 1999. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on March 17, 2021.

Headquarters
24-4, Achasan-Ro, 5-Gil, Seongdong-Gu
Seoul; Seoul;

Contact Details: Purchase the Bio Dyne Co.,Ltd. report to view the information.

Website: http://www.biodyne.asia

Basic Information
Total Employees:
Purchase the Bio Dyne Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Bio Dyne Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Bio Dyne Co.,Ltd. report to view the information.
Incorporation Date:
October 08, 1999
Key Executives
Purchase this report to view the information.
CEO
Purchase this report to view the information.
Non-Executive Independent Director
Purchase this report to view the information.
Auditor
Purchase this report to view the information.
Senior Managing Director
Purchase this report to view the information.
Managing Director
Company Performance
Financial values in the chart are available after Bio Dyne Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
224.46%
Total operating revenue
225.88%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-0.89%
Total equity
14.7%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-0.03%
Quick Ratio
13.41%
Cash Ratio
7.27%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?